UnitedHealth Earnings Preview: Can Cost Discipline Restore Confidence?
$UnitedHealth(UNH)$
The broader managed-care backdrop has changed
The group started 2026 under heavy policy pressure after CMS proposed only a 0.09% average Medicare Advantage payment increase for 2027 in January, a result that came in far below what investors had been hoping for. But sentiment improved sharply in April after CMS finalized a 2.48% increase, and Reuters reported that, including risk-score-related effects, total payment growth is expected to be around 5%. That shift was enough to trigger a strong rebound across major health insurers, including UnitedHealth. In other words, sector pricing has moved from“policy shock”to“policy relief.”
Still, this is not a return to a high-certainty environment. Elevance has already framed 2026 as a year of“execution and repositioning” across Medicaid, Medicare Advantage, and ACA plans, while Humana's 2026 profit guidance came in below Wall Street expectations, reflecting the ongoing pressure from lower Star ratings and elevated cost trends. So even though the industry-level policy overhang has eased, the core operational pressures around cost, pricing, and member mix have not disappeared. That is the right lens for reading UnitedHealth's quarter.
Three Things to Keep in Mind
The first thing to watch is the insurance-side cost trend. The key reason UnitedHealth cut its 2025 outlook last April was a surge in care activity inside its Medicare Advantage business that became visible late in the quarter, especially in physician and outpatient services. For 2026, management is guiding to a consolidated medical care ratio of 88.8% plus or minus 50 basis points, slightly better than the reported 89.1% in 2025, with that improvement tied to repricing and tighter cost discipline. That makes first-quarter cost performance far more important than headline revenue. If costs again run above plan, investors will likely move quickly to question the credibility of the full-year recovery story.
The second issue is Optum, especially Optum Health. This remains the most important internal swing factor in the story. The market already knows UnitedHealthcare can still provide scale and recurring cash flow. The bigger debate is whether Optum Health can stop dragging on overall earnings quality. In 2025, Optum Health revenue fell 3%, while adjusted operating earnings dropped to $2.3 billion from $7.9 billion a year earlier, as reimbursement pressure and elevated medical costs hit the business hard. That is why first-quarter commentary on patient mix, reimbursement alignment, and early margin stabilization may matter more than a small EPS beat or miss.
The third issue is whether the broader repair path for 2026 still holds. UnitedHealth's core message this year is not rapid growth; it is deliberate resizing followed by margin repair. The company’s official outlook calls for revenue of more than $439 billion in 2026, down about 2% from 2025, reflecting what management explicitly describes as“planned right-sizing across the enterprise.”UnitedHealthcare revenue is expected to exceed $335 billion, but total membership is projected to fall to a range of 46.9 million to 47.5 million. At the same time, UnitedHealthcare operating earnings are guided to more than $10.8 billion, while Optum operating earnings are expected to exceed $13.2 billion. The message is clear: management is prioritizing mix, pricing, and margin over pure enrollment growth.
Options Market Signals
UNH's options setup suggests caution, but not outright panic, ahead of earnings. Open interest stands at about 1.33 million contracts, while the put-call ratio at 0.66 still points to a call-heavy market overall, even though the ratio has been trending higher versus late 2025, indicating that downside hedging has picked up as the stock heads into its April 21 report. At the same time, implied volatility around 37.9% sits slightly below historical volatility of 40.4%, with IV Rank at 18 and IV Percentile at 42%, which means option premiums are elevated enough to reflect event risk, but not stretched enough to suggest extreme fear or crowded downside protection. That fits with broader earnings-event pricing, as traders are currently bracing for roughly a 5.7% to 6.0% post-results move in either direction.
Put differently, the options market is not signaling a strong directional consensus, it is signaling a market that is willing to own upside exposure while still paying for protection into a potentially narrative-shifting quarter.
Summary
So the cleanest way to read this quarter is in three steps.
– Look at the medical care ratio and UnitedHealthcare margin to see whether insurance-side costs are tracking back toward plan.
– Focus on Optum Health margins and management commentary to judge whether the biggest internal drag is beginning to stabilize.
– Check whether management fully reaffirms its major 2026 targets, especially adjusted EPS above $17.75, Optum operating earnings above $13.2 billion, and UnitedHealthcare operating earnings above $10.8 billion.
If all three hold, the market has a stronger case to view UnitedHealth as a high-quality asset in recovery. If any of them meaningfully weaken—especially on medical costs or Optum—the stock's earnings-repair narrative may have to be priced again from a lower base.
@TigerStars @CaptainTiger @TigerWire @Daily_Discussion @Tiger_chat @Tiger_comments @MillionaireTiger
Comments